Xylem Inc. (XYL) News
Track canonical SquawkNews coverage tagged to XYL, Xylem Inc.. This hub brings together deduplicated headlines about united states, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 20 indexed stories across 11 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Xylem Coverage Assumed by Wolfe Research at Peer Perform
Ratings actions from Benzinga
NEWS | Sep 15, 2026, 11:32 AM UTC
L
Xylem files for five-year $1.50 billion revolving credit facility
Xylem entered a five-year revolving credit facility agreement for up to $1.50 billion, and the terms are referenced in an SEC filing.
REGULATION | Sep 09, 2026, 11:08 AM UTC
L
Xylem secures $1.5B five-year revolver, expandable to $2.0B
Xylem entered a new senior unsecured five-year revolving credit facility for up to $1.5 billion, expandable to $2.0 billion, in USD and EUR. It terminated its March 1, 2023 $1.0 billion revolver.
CENTRAL_BANK | Sep 09, 2026, 10:05 AM UTC
H
Xylem shares fall after executive transition; Q3 and FY26 sales guidance affirmed
Xylem’s shares trade lower after the company announces an executive transition and affirms its Q3 and FY26 sales guidance, which is below analyst estimates.
EARNINGS | Aug 18, 2026, 06:28 PM UTC
H
Xylem affirms FY2026 adjusted EPS and sales guidance range
Xylem affirms FY2026 adjusted EPS guidance of $5.55–$5.70 versus a $5.54 analyst estimate, and affirms FY2026 sales guidance of $9.200B versus a $9.254B estimate.
EARNINGS | Aug 18, 2026, 02:56 PM UTC
H
Xylem affirms Q3 adjusted EPS and sales guidance ranges
Xylem (NYSE: XYL) affirms Q3 adjusted EPS guidance of $1.42-$1.47 versus a $1.46 analyst estimate and maintains Q3 sales outlook at $2.300 billion versus $2.316 billion expected.
EARNINGS | Aug 18, 2026, 02:56 PM UTC
L
Xylem appoints Andrea van der Berg chief financial officer
Xylem appoints Andrea van der Berg as its chief financial officer, according to a TradeXchange Newsdesk update for ticker XYL.
EQUITY | Aug 18, 2026, 01:07 PM UTC
L
Xylem declares third-quarter dividend of 43 cents per share
Xylem (XYL) declares a third-quarter dividend of 43 cents per share, with no further details on pay date or ex-date provided in the source.
EQUITY | Aug 13, 2026, 08:18 PM UTC
L
Xylem appoints D. Christian Koch to board of directors
Xylem (XYL) appoints D. Christian Koch to its board of directors, according to the provided update.
REGULATION | Aug 13, 2026, 08:11 PM UTC
L
XYL - Xylem to Acquire Cornell Pump and Roper Pump, Strengthening Industrial Presence in High Growth Sectors
XYL - Xylem to Acquire Cornell Pump and Roper Pump, Strengthening Industrial Presence in High Growth Sectors
MNA | Aug 11, 2026, 12:39 PM UTC
L
BLZE, STLA, UCAR, VWAV, XYL: File Mixed Shelf Offerings
Companies file mixed shelf offerings
EQUITY | Aug 03, 2026, 09:52 PM UTC
H
Xylem raises FY26 adjusted EPS view to $5.55-$5.70 from $5.35-$5.60
Xylem now forecasts...
EARNINGS | Jul 28, 2026, 10:59 AM UTC
H
Xylem Raises FY2026 Adj EPS Guidance from $5.35-$5.60 to $5.55-$5.70 vs $5.54 Est; Narrows FY2026 Sales Guidance from $9.200B-$9.300B to $9.
Xylem (NYSE: XYL ) raises FY2026 Adj EPS guidance from $5.35-$5.60 to $5.55-$5.70 vs $5.54 analyst estimate. Narrows FY2026 sales outlook from $9.200 billion-$9.300 billion to $9.200 billion vs $9.254 billion estimate.
EARNINGS | Jul 28, 2026, 10:56 AM UTC
H
XYL Xylem RESULTS: Q2, Q2 ADJ Net Income $345M vs. EST $323.7M, Q2 ADJ EPS $1.46 vs. EST $1.34, Q2 EPS $1.11, Q2 REV $2.300B vs. EST $2.341B
XYL Xylem RESULTS: Q2, Q2 ADJ Net Income $345M vs. EST $323.7M, Q2 ADJ EPS $1.46 vs. EST $1.34, Q2 EPS $1.11, Q2 REV $2.300B vs. EST $2.341B, Xylem Earnings Notes:, Outlook FY ADJ EBITDA margin 23.1-23.5%
EARNINGS | Jul 28, 2026, 10:55 AM UTC
L
Implied EPS movers for tomorrow AM: KO +/-2.8%, GLW +/-10.6%, BA +/-4.7%, SHW +/-6.1%, SPGI +/-4.5%, HLT +/-3.6%, PCAR +/-6.5%, RCL +/-7.3%,
Implied EPS movers for tomorrow AM: KO +/-2.8%, GLW +/-10.6%, BA +/-4.7%, SHW +/-6.1%, SPGI +/-4.5%, HLT +/-3.6%, PCAR +/-6.5%, RCL +/-7.3%, UPS +/-5.6%, AMT +/-5.9%, ITW +/-5.3%, CARR +/-5.5%, ECL +/-6.0%, CNC +/-8.1%,
EQUITY | Jul 27, 2026, 05:42 PM UTC
L
XYL Downgrade to Neutral (from Overweight), PT to $130 (from $140) @ JPMC
XYL Downgrade to Neutral (from Overweight), PT to $130 (from $140) @ JPMC
EQUITY | Jul 21, 2026, 11:49 AM UTC
L
XYL Reiterate Outperform and $168 PT - counter to the lingering concerns of some investors, remain confident in Xylem's normalized organic g
XYL Reiterate Outperform and $168 PT - counter to the lingering concerns of some investors, remain confident in Xylem's normalized organic growth and margin expansion trajectory @ OPCO
EQUITY | Jul 14, 2026, 01:24 PM UTC